Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
---|
02/05/1992 | EP0469066A1 Improved amplified nucleic acid hybridization assays for hbv. |
02/04/1992 | US5086176 Adenosine antagonist |
02/04/1992 | US5086044 Administering 3'-azido-3'-deoxythymidine or its mono-, di-or triphosphate |
02/04/1992 | US5085992 Culturing striptomyces under aerobic conditions, angitensin II antagonist |
01/28/1992 | WO1992002533A1 Hydroxyl-protecting groups orthogonally removable by reduction and their use in the chemical synthesis of oligonucleotides |
01/28/1992 | WO1992002528A1 Incorporation of selectably clevable and/or abasic sites into oligonucleotide chains and reagents therefor |
01/28/1992 | WO1992002526A1 Large comb-type branched polynucleotides |
01/28/1992 | US5084445 3'-azido-2',3'-dideoxy-5-methylcytidine |
01/28/1992 | CA2088257A1 Incorporation of selectably clevable and/or abasic sites into oligonucleotide chains and reagents therefor |
01/28/1992 | CA2088255A1 Hydroxyl-protecting groups orthogonally removable by reduction and their use in the chemical synthesis of oligonucleotides |
01/28/1992 | CA2087961A1 Large comb-type branched polynucleotides |
01/28/1992 | CA2046053A1 Antiviral antibiotic bu-4224v |
01/24/1992 | WO1992001700A1 2'-fluorofuranosyl derivatives and novel method of preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides |
01/23/1992 | WO1992000980A1 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
01/22/1992 | EP0467715A1 Microbial transformation process for antihypertensive products |
01/21/1992 | US5082829 AICA riboside prodrugs |
01/21/1992 | CA1294572C Compound having hypoxanthine base, its use and process for producing it |
01/21/1992 | CA1294548C2 Dehydrated liposomes |
01/20/1992 | WO1992001456A1 Heterocyclic compounds |
01/20/1992 | CA2047029A1 Microbial transformation process for antihypertensive products |
01/15/1992 | EP0466365A2 Novel immunosuppressant fermentation products of a microorganism |
01/15/1992 | CN1057844A Process for preparation of pyrimidine nucleosides |
01/14/1992 | WO1992000988A1 Targeted drug delivery via phosphonate derivatives |
01/14/1992 | CA2087194A1 Targeted drug delivery via phosphonate derivatives |
01/09/1992 | WO1992000314A1 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
01/09/1992 | WO1992000313A1 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
01/08/1992 | EP0465426A1 Heteroatoms-containing tricyclic compounds |
01/08/1992 | EP0465164A1 Process for the preparation of pyrimidine nucleosides |
01/08/1992 | EP0465121A1 Stable salts of 4"-deoxy-4"-epimethylamino avermectin B1a/B1b |
01/08/1992 | EP0464642A1 Pyrimidine derivatives, their preparation and use as well as medicaments containing them |
01/08/1992 | EP0464638A2 Oligonucleotide analogues with terminal 3'-3' or 5'-5'-internucleotide linkages |
01/08/1992 | EP0464206A1 Drug for improving brain function |
01/08/1992 | EP0464137A1 Inhibition of hiv using synergistic combinations of nucleoside derivatives |
01/08/1992 | EP0464112A1 A process for the preparation of 9-substituted guanine derivatives and intermediates for use in the process. |
01/07/1992 | US5079235 5-Substituted Pyrimidine Nucleosides |
01/07/1992 | CA2020648A1 Aqueous alkylation process |
01/07/1992 | CA1293938C Purification of synthetic oligomers |
01/04/1992 | CA2046040A1 Immunosuppressant fermentation products of a microorganism |
01/03/1992 | CA2045989A1 Heteroatoms-containing tricyclic compounds |
01/02/1992 | EP0463690A1 Antagonists of immunosuppressive macrolides |
01/02/1992 | EP0463677A2 Process for the glycosylation of avermectin aglycones |
12/31/1991 | US5077403 Process to prepare pyrimidine nucleosides |
12/31/1991 | US5077398 Parasiticides; seeding, crystallization in hydrocarbon, alcohol solvent mixture in hot oil |
12/31/1991 | US5077279 Treating AIDS |
12/31/1991 | US5077278 Non-natural demethylavermectins compositions and method of use |
12/31/1991 | CA2045939A1 Process for the preparation of pyrimidine nucleosides |
12/31/1991 | CA1293722C2 N-6 substituted adenosine derivatives as cardiac vasodilators |
12/31/1991 | CA1293721C2 N-6 substituted adenosine derivatives as cardiac vasodilators |
12/31/1991 | CA1293678C Composition and method for stabilization of dinucleotides |
12/28/1991 | WO1992000312A1 Process for the preparation of 9-beta-d-arabinofuranosyl-2-fluoroadenine 5'-phosphate |
12/26/1991 | WO1991019813A1 Nucleic acid ligands |
12/26/1991 | WO1991019727A1 5'-hydrogenphosphonates and 5'-methylphosphonates of sugar modified nucleosides, compositions and uses thereof |
12/26/1991 | WO1991019726A1 Ether lipid-nucleoside covalent conjugates |
12/26/1991 | WO1991019713A1 Pyrimidine nucleoside derivative |
12/26/1991 | CA2044846A1 Antagonists of immunosuppressive macrolides |
12/24/1991 | US5075289 Improved activity and therapeutic ratios |
12/24/1991 | CA1293447C Use of 3'-deoxythymidin-2'-ene (3'-deoxy-2', 3'- didehydrothymidine)in treating patients infected with retroviruses |
12/23/1991 | CA2044875A1 Process for the glycosylation of avermectin agylcones |
12/18/1991 | EP0462075A2 Use of uridine in the pharmacological treatment of the peripheral complications of diabetes |
12/18/1991 | EP0461815A1 Anti-HBV pyrimidine nucleoside |
12/18/1991 | EP0461520A2 Oxetanocin G anhydride crystals and process for producing the same |
12/18/1991 | EP0461407A1 Improved process for the preparation of 2-amino(2,3,5-tri-O-benzyl-beta-D-arabinofuranosyl)adenine |
12/18/1991 | EP0461225A1 Circumvention of human tumor drug resistance |
12/17/1991 | US5073633 BMY-41950 antitumor antibiotic |
12/17/1991 | US5073546 Antiinflammatory, analgesic, anticholesterol agent; psychological and nervous disorders |
12/16/1991 | WO1991019728A1 Nucleotide derivative |
12/16/1991 | CA2085239A1 Nucleotide derivatives |
12/14/1991 | WO1991019721A1 Phosphorous produgs |
12/12/1991 | WO1991012021A3 Therapeutic agents, and intermediates for the synthesis thereof |
12/11/1991 | EP0460078A1 Pharmaceutically active agents that impede amyloid formation in vivo |
12/11/1991 | EP0460045A1 Nucleoside analogues |
12/10/1991 | US5072004 Using blocking, deblocking strategy |
12/10/1991 | US5071974 Compositions and methods for the synthesis of oligonucleotides having 5'-phosphorylated termini |
12/10/1991 | CA2044125A1 Anti-hbv pyrimidine nucleoside |
12/10/1991 | CA1292987C Pyrimidine derivatives |
12/04/1991 | EP0458901A1 Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
12/04/1991 | CN1014990B 5-pyrimidinecarboxamides and treatment of leukemia and tumors therewith |
12/03/1991 | US5070079 Pharmaceutical compositions containing cytidine monophosphate of 5-acetamido-3-, 5-d-deoxy-d-glycero-d-galacto-nonulosamic acid |
12/03/1991 | US5070078 Adenovirus |
11/30/1991 | WO1991018914A1 Synthesis of glycerol di- and triphosphate derivatives |
11/30/1991 | CA2083961A1 Synthesis of glycerol di- and triphosphate derivatives |
11/28/1991 | WO1991018003A1 Antitumor be-13793c derivative |
11/28/1991 | WO1991018002A1 Nucleosides as synthones for rna-synthesis |
11/28/1991 | WO1991005754A3 Derivatives of long-chain fatty alcohols and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
11/27/1991 | EP0458519A2 Synthesis of nucleotide and nucleoside derivatives |
11/26/1991 | US5068323 Thermally re-arranged FK-506 derivatives having immunosuppressant activity |
11/26/1991 | US5068320 2-amino-6-(cyclopropylamino)purine-9-β-D-2',3'-dideoxyribofuranoside and its pharmaceutically acceptable salts |
11/26/1991 | CA1292468C Nucleosides of 5-monofluoromethyluracil and 5- difluoromethyluracil |
11/25/1991 | CA2042545A1 Synthesis of nucleotide and nucleoside derivatives |
11/21/1991 | EP0457570A1 Nucleoside-phospholipid conjugate |
11/21/1991 | EP0457517A1 Avermectin derivatives with a spacer inserted between the disaccharide and the aglycone useful as antiparastic agents |
11/21/1991 | EP0457336A2 Use of mizoribine for the treatment or prevention of multiple sclerosis |
11/21/1991 | EP0457326A1 Antiviral agents |
11/21/1991 | DE4015735A1 Nukleoside als synthone fuer die rna-synthese Nucleosides as synthons for the synthesis of rna |
11/19/1991 | US5066500 Infant formulas and nutrition products enriched with nucleosides and/or nucleotides and processes for their preparation |
11/18/1991 | CA2042795A1 Antiviral agents |
11/18/1991 | CA2042752A1 Novel application of 4-carbamoyl-1- b -d-ribofuranosyl imidazolium-5-olate |
11/15/1991 | CA2042418A1 Avermectin derivatives with a spacer inserted between the disaccharide and the aglycone useful as antiparasitic agents |
11/14/1991 | WO1991017172A1 Novel mycalamides with antitumor and antiviral activity |
11/13/1991 | EP0456509A1 Derivatives of 3' - and 3"-0-desmethyl avermectin compounds |